This is the authors' abstract. We don't add key points for this paper.
Estimating para‐aminohippuric acid (PAH) as a potential bioindicator for diagnosing renal diseases is gaining prominence. Hence, this study aims to develop a novel nanoprobe using cysteine‐mediated N, S‐graphene quantum dots (N, S‐GQDs) embedded in UiO metal–organic frameworks (N, S‐GQDs@UiO‐MOFs) for PAH monitoring. Simultaneous green synthesis and doping of GQDs were initially done using Alstonia scholaris leaves and L‐cysteine via the one‐pot hydrothermal method to enhance their selectivity and optical properties. Fluorescent UiO‐MOFs were then synthesized by 2‐aminoterephthalic acid (2‐ATA) and zirconium tetrachloride (ZrCl 4 ) providing a large surface area suitable for decorating N, S‐GQDs. Adding copper ions (Cu II) results in FL quenching (turn‐off) to the probe solution. In contrast, PAH addition led to FL recovery (turn‐on), attributed to interaction with the amino functionality of PAH and the formation of a Cu (II)‐PAH complex. The developed sensor exhibited a broad dynamic range (3 –17 ng mL −1 ), an impressive detection limit (LOD: 662 pg mL −1 ), and a quantification limit (LOQ: 2 ng mL −1 ). Validation in artificial urine confirmed the sensor's specificity and suitability for real‐time PAH analysis, demonstrating good stability, repeatability, and selectivity. The integrated N, S‐GQDs@UiO‐MOFs nanoprobe shows promise as a preferred method for PAH detection in clinical samples.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Manyar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: